Standard BioTools
LAB
LAB
68 hedge funds and large institutions have $54.2M invested in Standard BioTools in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 18 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 22
65% less call options, than puts
Call options by funds: $37K | Put options by funds: $107K
Holders
68
Holding in Top 10
1
Calls
$37K
Puts
$107K
Top Buyers
| 1 | +$819K | |
| 2 | +$245K | |
| 3 | +$199K | |
| 4 |
JCP
Jennifer C. Price
|
+$139K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$58.5K |
Top Sellers
| 1 | -$676K | |
| 2 | -$363K | |
| 3 | -$278K | |
| 4 |
E
Ergoteles
New York
|
-$209K |
| 5 |
Millennium Management
New York
|
-$153K |